CAC Software vs AI-ECG Platform

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

CAC Software

by 4DMedical (Imbio CAC Software)

AI-ECG Platform

by Shenzhen Carewell Electronics Co., Ltd.

AI Verdict

While both tools fall under the umbrella of Cardiology AI, they address distinct diagnostic modalities and clinical questions. Imbio's CAC Software analyzes CT scans to quantify coronary artery calcification for cardiovascular risk assessment, whereas Shenzhen Carewell Electronics' AI-ECG Platform interprets 12-lead resting ECGs for the diagnosis of various electrical cardiac conditions. Therefore, they serve complementary roles in cardiac diagnostics rather than being direct competitors.

Choose CAC Software if…

Choose Imbio's CAC Software if your primary objective is to accurately quantify coronary artery calcification from non-contrast chest CT scans. This tool is ideal for radiologists and cardiologists who need automated Agatston scores, arterial age, and 3D visualizations to enhance risk assessment for coronary artery disease. It integrates into existing DICOM viewing workflows for efficient, non-invasive analysis.

View CAC Software →

Choose AI-ECG Platform if…

Choose Shenzhen Carewell Electronics' AI-ECG Platform if you require rapid, highly accurate AI-driven analysis and diagnosis of 12-lead resting ECGs. This platform is best suited for physicians in cardiology, emergency medicine, or internal medicine who need assistance in quickly identifying arrhythmias, myocardial ischemia, and other major cardiovascular diseases. Its hardware-independent nature and fast diagnosis time make it valuable for high-volume ECG interpretation.

View AI-ECG Platform →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	CAC Software	AI-ECG Platform
Pricing	Unknown	Contact for pricing
Deployment	Cloud-based (SaaS), integrates with PACS	Workstation (with GPU), web-based portal, Windows-based diagnostic client
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	CAC Software	AI-ECG Platform
Primary Function	Automated image post-processing for coronary artery calcification (CAC) from non-contrast chest CT.	AI automatic analysis and diagnosis system for 12-lead resting ECGs.
Analyzed Data Type	Non-contrast, chest computed tomography (CT).	12-lead resting ECGs (supports Carewell ECG, HL7 aECG, DICOM ECG, SCP ECG, MFER ECG).
Key Outputs/Analysis	Agatston score, arterial age, calcified lesion mass and volume, 3D visualizations, annotated images.	Diagnoses arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction.
Company	Imbio	Shenzhen Carewell Electronics Co., Ltd.
Processing Speed/Benefit	Supports risk assessment for coronary artery disease.	Rapid diagnosis in approximately 3 seconds.

Videos

Demos, reviews, and walkthroughs featuring CAC Software and AI-ECG Platform.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What types of cardiac conditions do these tools help diagnose or assess?

Tool A, Imbio's CAC Software, is designed to help determine the location and quantify calcification within coronary arteries from non-contrast chest CT scans, supporting risk assessment for coronary artery disease. Tool B, Shenzhen Carewell Electronics' AI-ECG Platform, assists physicians in interpreting 12-lead resting ECGs to diagnose conditions such as arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction.

What are the primary data inputs required for each tool?

Imbio's CAC Software analyzes non-contrast chest computed tomography (CT) images to identify and quantify coronary artery calcification. The AI-ECG Platform by Shenzhen Carewell Electronics is designed to interpret 12-lead resting ECGs and is compatible with most ECG machines, supporting various ECG data formats like Carewell ECG, HL7 aECG, DICOM ECG, SCP ECG, and MFER ECG.

How do these tools integrate into existing clinical workflows?

Imbio's CAC Software integrates into existing DICOM viewing workflows, providing outputs such as 3D visualizations and annotated images. The AI-ECG Platform is hardware independent and compatible with most ECG machines, offering a web-based management portal and a Windows-based diagnostic client for professional ECG review and report generation.

What specific metrics or diagnostic outputs do these platforms provide?

Imbio's CAC Software outputs the Agatston score, arterial age, and calcified lesion mass and volume, along with 3D visualizations and annotated images. The AI-ECG Platform provides automatic analysis and diagnosis for major cardiovascular diseases, including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction, with over 95% accuracy.

Can you clarify the regulatory clearance and compliance status for each tool?

Both Imbio's CAC Software and Shenzhen Carewell Electronics' AI-ECG Platform are FDA-cleared. Imbio's CAC Software is explicitly stated to be HIPAA compliant and has a Business Associate Agreement (BAA). The AI-ECG Platform is noted as 'likely' having a BAA and being HIPAA compliant, though not explicitly stated on its public website.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform